NL-04-2067, Report of Unsatisfactory Performance of Kroll Laboratory
| ML043020257 | |
| Person / Time | |
|---|---|
| Site: | Farley  |
| Issue date: | 10/25/2004 |
| From: | Stinson L Southern Nuclear Operating Co |
| To: | Document Control Desk, Office of Nuclear Reactor Regulation |
| References | |
| NL-04-2067 | |
| Download: ML043020257 (3) | |
Text
L M. Stinson (Mike)
Southern Nuclear Vice President Operating Company, Inc.
40 Inverness Center Parkway Post Office Box 1295 Birmingham. Alabama 35201 Tel 205.992.5181 Fax 205.992.0341 SOUUTHERN NA October 25, 2004 COMPANY Energy to Serve Your World'w Docket Nos.:
50-348 NL-04-2067 50-364 U. S. Nuclear Regulatory Commission ATFN: Document Control Desk Washington, D. C. 20555-0001 Joseph M. Farley Nuclear Plant Report of Unsatisfactory Performance of Kroll Laboratory Ladies and Gentlemen:
Southern Nuclear Operating Company (SNC), the licensed operator for the Joseph M.
Farley Nuclear Plant (FNP) uses Kroll Laboratory Specialists, Inc. (Kroll), Gretna, Louisiana as a laboratory and testing facility in accordance with 10 CFR 26. In accordance with 10 CFR 26, Appendix A, 2.8(e)(4), SNC is providing this letter and its Enclosure to document unsatisfactory performance of Kroll and corrective action taken to address this incident.
On September 13, 2004, SNC became aware of a mistake made by Kroll in which a typographical error occurred in the field containing the donor ID as reported on the laboratory drug test report. SNC uses this field to reference the site-specific ID for internal program administration. The Chain of Custody Form submitted with the specimen contained a pre-printed label with the site-specific ID. This was keyed incorrectly into the laboratory system by Kroll personnel resulting in the typographical error on the drug test report - specifically, F041628 was keyed as F041620. The laboratory report contained the correct laboratory accession number - 8273003 and specimen ID number-50691887. These are numbers which Kroll uses to identify the specimen throughout their testing process.
Upon submission to the laboratory, F041628 was a performance specimen spiked with benzoylecgonine and had tested presumptive positive for cocaine during onsite testing.
F 041620 was an individual's specimen presumptive positive for opiates during onsite testing.
When the laboratory report on F041620, positive for cocaine was received at the MRO's office, the MRO staff contacted the FNP Fitness for Duty Coordinator and requested an MRO interview with the individual that provided the specimen. The individual was contacted and scheduled for the MRO interview. During the interview process, the MRO noticed the discrepancy in the site-specific ID as recorded on the laboratory report. lie immediately notified the FNP Fitness for Duty Coordinator and did not proceed with the interview. The FNP Fitness for Duty Coordinator contacted the SNC Corporate Health tC)R
U. S. Nuclear Regulatory Commission NL-04-2067 Page 2 Services Coordinator who notified the laboratory certifying scientist of the error and requested an investigation and a corrected laboratory report An audit performed by Kroll laboratory personnel revealed that only the site-specific ID number contained the error. All other documentation to the MRO contained the correct identification numbers. Corrected reports were issued and processed according to applicable internal procedures. F 041628 was correctly confirmed as positive for cocaine. F 041620 did not confirm for opiates and was ruled negative by the MRO. SNC has determined that unsatisfactory performance did occur; therefore, in accordance with the cited regulation, SNC is submitting this report and corrective action taken to address this incident.
SNC began utilizing Kroll in June 2004. This is the first instance of an identified laboratory error of any kind. The SNC Fitness for Duty staff will continue to exercise diligence in monitoring results and reports. SNC considers the investigation performed, deficiencies identified, and corrective actions sufficient to address this incident.
This letter contains no NRC commitments.
Sincerely, L. M. Stinson LMS/JMG
Enclosure:
Kroll Report dated September29, 2004 cc:
Southern Nuclear Operating Company Mr. J. T. Gasser, Executive Vice President Mr. J. R. Johnson, General Manager - Plant Farley RTYPE: CFA04.054; LC# 14163 U. S. Nuclear Rewulatory Commission Dr. W. D. Travers, Regional Administrator Mr. S. E. Peters, NRR Project Manager - Farley Mr. C. A. Patterson, Senior Resident Inspector - Farley
Enclosure to NL-0-4-2067 Page I of I Enclosure to NL-04-2067 Page 1 of I Kroll Laboratory Specialists. Inc.
I I I I Newton Street Gretna, LA 70053 (800) 433-3823 Tc Jiist Ccnsufri g Cemparry Koli Lbraty Specialists, hic.
September 29,2004 Billie Rooks Southern Nuclear Operating Company Sarety & Health Department P.O. Box 1295 B3irmingham, AL 35201 Deanr Billie:
May this letter serve to document our conversation of September 24. 2004. Kroll rcecived Specimen ID 506918X7 (LUboratory Accession number 8273003) on 91A012004 and reported the result at S Bcn-4oylccgonine (cocaine metabolitc) positive on 91112004. The donor ID field contained a typographical error. Instead of F04 1628, it was entered as F04 1620. The report included the signed Chain of Custody as an attachment that contained the corrcct donor ID. Once Kroll was notified, the typographical error was corrected. a corrected report was issued and the responsible individuals were counseled.
Kroll received specimen ID 50691888 on 911012004 and It was reported on 09/11(20o4 as a negative result. There were no errors on this reporL We arc very sorry that this typographical error occurred and regret any problems Llhat it may have causmed you.
Sincerely, David A. Green, Ph.D.. DA13CC, FACD Laboratory Director